SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by McAdam LLC

McAdam LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,212 shares of the exchange traded fund’s stock after buying an additional 295 shares during the quarter. McAdam LLC’s holdings in SPDR S&P Biotech ETF were worth $733,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Eagle Wealth Strategies LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $470,000. Conservest Capital Advisors Inc. grew its stake in SPDR S&P Biotech ETF by 2.4% during the 4th quarter. Conservest Capital Advisors Inc. now owns 38,991 shares of the exchange traded fund’s stock worth $3,482,000 after purchasing an additional 912 shares in the last quarter. Pursue Wealth Partners LLC increased its holdings in SPDR S&P Biotech ETF by 17.5% during the 4th quarter. Pursue Wealth Partners LLC now owns 13,846 shares of the exchange traded fund’s stock worth $1,236,000 after purchasing an additional 2,060 shares during the period. Transcend Capital Advisors LLC raised its position in SPDR S&P Biotech ETF by 52.5% in the 4th quarter. Transcend Capital Advisors LLC now owns 48,204 shares of the exchange traded fund’s stock valued at $4,304,000 after purchasing an additional 16,605 shares in the last quarter. Finally, K.J. Harrison & Partners Inc acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $1,858,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $85.60 on Tuesday. The company’s 50 day moving average price is $92.54 and its 200 day moving average price is $84.94. The firm has a market capitalization of $6.65 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.